Tech Company Financing Transactions

MapLight Therapeutics Funding Round

MapLight Therapeutics secured a $225 million Series C funding round on 10/30/2023. Investors included 5AM Ventures, Cowen Healthcare Investments and Novo Holdings.

Transaction Overview

Company Name
MapLight Therapeutics
Announced On
10/30/2023
Transaction Type
Venture Equity
Amount
$225,000,000
Round
Series C
Investors

5AM Ventures (Lead Investor)

Cowen Healthcare Investments (Lead Investor)

Novo Holdings (Lead Investor)

Proceeds Purpose
This round will advance ML-007C-MA, a novel M1/M4 muscarinic agonist agent combined with a precision matched peripheral muscarinic antagonist, into Phase 2 trials for schizophrenia and Alzheimer's disease psychosis in 2024, and enable continued progress on the company's other pipeline programs.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1500 District Avenue
Burlington, MA 01803
USA
Phone
Undisclosed
Website
www.maplightrx.com
Email Address
[email protected]
Overview
Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).
Profile
MapLight Therapeutics LinkedIn Company Profile
Social Media
MapLight Therapeutics Company Twitter Account
Company News
MapLight Therapeutics News
Facebook
MapLight Therapeutics on Facebook
YouTube
MapLight Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Christopher Kroeger
  Christopher Kroeger LinkedIn Profile  Christopher Kroeger Twitter Account  Christopher Kroeger News  Christopher Kroeger on Facebook
Chief Financial Officer
Jonathan Gillis
  Jonathan Gillis LinkedIn Profile  Jonathan Gillis Twitter Account  Jonathan Gillis News  Jonathan Gillis on Facebook
Chief Scientific Officer
James Lillie
  James Lillie LinkedIn Profile  James Lillie Twitter Account  James Lillie News  James Lillie on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/30/2023: Triplebar venture capital transaction
Next: 10/30/2023: Urbix venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to report on tech company VC transactions. All VC database entries reported here are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.